Strategic Financing SFJ operates a financing and regulatory resource-backed model for clinical development, presenting a potential sales angle for partners seeking non-dilutive funding and accelerated pathways to approval.

Global Reach With offices across the US, Europe, Japan, Singapore, Cayman Islands, and Korea, SFJ offers multinational regulatory navigation and regional development support ideal for international partnerships and co-development opportunities.

Clinical Development Leadership SFJ provides end-to-end clinical development and regulatory expertise, enabling faster time-to-market for partners and a compelling value proposition for companies needing experienced oversight in global trials.

Notable Collaborations Historical partnerships with Merck, Nektar, PhaseBio, and Apellis highlight SFJ’s track record in oncology and immune-related programs, suggesting openness to new co-development and financing arrangements in high-potential assets.

Mid-Market Focus Revenue in the mid-range and a lean employee base indicate SFJ targets mid-sized biotech and specialty pharma clients seeking strategic development support without large-scale CRO engagements.